Description
Binds Keap1 and attenuates the degradation of Nrf2 at concentrations ≤25 nM, suppressing inflammatory signaling; inhibits tumor cell growth (GI50 = 260 nM), blocks NF-κB signaling, and decreases levels of cyclinD1; activates Nrf2 and provides cytoprotective effects when applied topically
Formal name: N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoro-propanamide
Synonyms: Omaveloxolone
Molecular weight: 554.7
CAS: 1474034-05-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Cell Signaling|NF-κB Signaling||Research Area|Cell Biology|Cell Signaling|NF-κB Signaling||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Immunology & Inflammation|Innate Immunity